ea0029p692 | Diabetes | ICEECE2012
Perez Rodriguez J.
, Morales Portillo C.
, Garcia Garcia C.
, Fernandez Pena I.
, Hernando Jimenez V.
, Serrano Olmedo I.
, De la Cuesta Mayor C.
, Sendon Perez
Objectives: Evaluate the impact of the therapy with GLP-1 analogues (exenatide) toguether with basal insulin in glycemic control and weight of patients with type 2 diabetes mellitus poorly controlled.Materials and methods: We analyzed 37 patients with type 2 diabetes with poor glycemic control and obesity, treatment with exenatide and basal insulin. As pre-treatment 56.7% of our patients were with basal insulin, 10.8% with insulin mixtures and 32.4% with...